BASI - バイオアナリティカル・システムズ (Bioanalytical Systems Inc.) バイオアナリティカル・システムズ

 BASIのチャート


 BASIの企業情報

symbol BASI
会社名 Bioanalytical Systems Inc. (バイオアナリティカル・システムズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Commercial Physical_Biological Resarch  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 バイオアナリティカル・システムズ(Bioanalytical Systems Inc.)は創薬・薬品開発サービスと分析装置を提供する受託研究会社である。同社の顧客及びパートナーには、製薬、生物技術、学術及び政府組織が含まれる。同社は研究サービス及び薬品開発ツールの販売より収益を獲得する。同社は小分子・生体分子の医薬品候補向け、研究者・臨床医の前臨床・臨床開発に関するニーズをサポートする。同社の主要顧客には、小さなスタートアップバイオ技術会社からグローバル製薬会社まで、分析化学、医薬品安全性評価、臨床試験、薬物代謝研究、薬物動態学及び基礎研究に従事する科学者が含まれる。同社は受託研究サービス及び研究製品を含む2つの事業区分により構成され、両事業とも薬物開発者の生物分析、前臨床及び臨床研究に関するニーズに対応する。   バイオアナリティカル・システムズは創薬・開発サ―ビスを提供する米国の開発業務受託機関。顧客やパ―トナ―は、製薬、バイオ・テクノロジ―、学術・政府機関が含まれる。委託研究サ―ビス事業は、スクリ―ニングや薬理試験、前臨床安全性試験、製剤開発、品質管理試験を提供。研究製品事業は、生態サンプル・システムと付属品の製造・販売。   Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market.
本社所在地 2701 Kent Avenue West Lafayette IN 47906 USA
代表者氏名 Gregory Cole Davis グレゴリーコールデイビス
代表者役職名 Interim Chairman of the Board
電話番号 +1 317-463-4527
設立年月日 1974年
市場名 NASDAQ Small Cap
ipoyear 1997年
従業員数 155人
url www.BASinc.com
nasdaq_url https://www.nasdaq.com/symbol/basi
adr_tso
EBITDA EBITDA(百万ドル) 1.91800
終値(lastsale) 1.5549
時価総額(marketcap) 15930381.2073
時価総額 時価総額(百万ドル) 14.85565
売上高 売上高(百万ドル) 23.23300
企業価値(EV) 企業価値(EV)(百万ドル) 17.75965
当期純利益 当期純利益(百万ドル) 0.23500
決算概要 決算概要 BRIEF: For the nine months ended 30 June 2018 Bioanalytical Systems Inc. revenues decreased 5% to $17.4M. Net income decreased 99% to $6K. Revenues reflect Service revenue decrease of 5% to $14.4M Product revenue decrease of 8% to $2.9M. Net income also reflects Selling increase of 14% to $917K (expense) Research and development increase of 26% to $430K (expense).

 BASIのテクニカル分析


 BASIのニュース

   The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout  2021/02/18 13:14:37 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17) Advaxis, Inc. (NASDAQ: ADXS ) Angion Biomedica Corp (NASDAQ: ANGN ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avanos Medical Inc (NYSE: AVNS ) Bausch Health Companies Inc (NYSE: BHC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bioatla Inc (NASDAQ: BCAB ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Chimerix Inc (NASDAQ: CMRX ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Endo International PLC (NASDAQ: ENDP ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Lucira Health Inc (NASDAQ: LHDX ) Nektar Therapeutics (NASDAQ: NKTR ) (announced a $150-million investment by SFJ Pharma for the Phase 2/3 registrational clinical study of BEMPEG plus Keytruda in patients with head and neck cancer) Oncolytics Biotech, Inc. (NASDAQ: ONCY ) (reacted to initiation of coverage by H.C.
   94 Biggest Movers From Yesterday  2021/02/11 09:04:36 Benzinga
Gainers Anchiano Therapeutics Ltd. (NASDAQ: ANCN ) jumped 187.4% to close at $7.96. Bio-Path Holdings, Inc. (NASDAQ: BPTH ) shares surged 126.4% to close at $11.77 on Wednesday after the company announced it received a third U.S. patent grant related to the manufacture of its platform technology. Viant Technology Inc. (NASDAQ: DSP ) climbed 90.9% to close at $47.72 after the company priced 10 million shares at $25 per share to rake in proceeds worth $250 million in an upsized initial public offering (IPO). United States Antimony Corporation (NYSE: UAMY ) climbed 82.6% to close at $1.78 after the company signed non-binding letter of interest regarding the potential supply of antimony with AMBRI. Sundial Growers Inc. (NASDAQ: SNDL ) surged 78.9% to close at $2.95 after jumping over 28% on Tuesday. Tengasco, Inc. (NYSE: TGC ) gained 77.2% to close at $5.05. Tilray, Inc. (NASDAQ: TLRY ) shares gained 50.9% to close at $63.91. Tilray shares jumped more than 40% on Tuesday after the company announced it has entered into an agreement with Grow Pharma to import and distribute Tilray's medical cannabis products into the United Kingdom.
   The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations  2021/01/13 12:25:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alkermes Plc (NASDAQ: ALKS ) AtriCure Inc. (NASDAQ: ATRC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BIOLASE Inc (NASDAQ: BIOL ) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) CareDx Inc (NASDAQ: CDNA ) Celsius Holdings, Inc. (NASDAQ: CELH ) DermTech Inc (NASDAQ: DMTK ) Dyne Therapeutics Inc (NASDAQ: DYN ) Edap Tms SA (NASDAQ: EDAP ) Evelo Biosciences Inc (NASDAQ: EVLO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Eyenovia Inc (NASDAQ: EYEN ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Guardant Health Inc (NASDAQ: GH ) (reacted to presentation at the JPMorgan Healthcare Conference) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Laboratory Corp.
   The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue  2021/01/12 13:15:54 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) 10X Genomics Inc (NASDAQ: TXG ) AbbVie Inc (NYSE: (ABBV) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) (reacted to the company's preliminary fourth-quarter results) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Biodesix Inc (NASDAQ: BDSX ) C4 Therapeutics Inc (NASDAQ: CCCC ) CareDx Inc (NASDAQ: CDNA ) (announced preliminary fourth-quarter results) Celsius Holdings, Inc. (NASDAQ: CELH ) Chimerix Inc (NASDAQ: CMRX ) Curis, Inc. (NASDAQ: CRIS ) Dyne Therapeutics Inc (NASDAQ: DYN ) (announced positive preclinical data from its myotonic dystrophy type 1 program) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive data from midphase study of its investigational asset in treating early symptomatic Alzheimer's) ESSA Pharma Inc (NASDAQ: EPIX ) EXACT Sciences Corporation (NASDAQ: EXAS ) (reacted to preliminary fourth-quarter results) Eyenovia Inc (NASDAQ: EYEN ) Guardant Health Inc (NASDAQ: GH ) Johnson & Johnson (NYSE: JNJ ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Oxford Immunotec Global PLC (NASDAQ: OXFD ) Pacira Biosciences Inc (NASDAQ: PCRX ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Syneos Health Inc (NASDAQ: SYNH ) Theratechnologies Inc (NASDAQ: THTX ) Twist Bioscience Corp (NASDAQ: TWST ) United Therapeutics Corporation (NASDAQ: UTHR ) Vascular Biogenics Ltd (NASDAQ: VBLT ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Jan.
   The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut  2020/12/03 12:46:12 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 2) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Beam Therapeutics Inc (NASDAQ: BEAM ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Fate Therapeutics Inc (NASDAQ: FATE ) Generation Bio Co (NASDAQ: GBIO ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Inhibrx Inc (NASDAQ: INBX ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Iovance Biotherapeutics Inc (NASDAQ: IOVA ) Inspire Medical Systems Inc (NYSE: INSP ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Larimar Therapeutics Inc (NASDAQ: LRMR ) Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) (reacted to positive outlook for the cancer drug it sold to Ispen, which opens the possibility of realizing potential milestone payments) Myovant Sciences Ltd (NYSE: MYOV ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Olema Pharmaceuticals Inc (NASDAQ: OLMA ) Oncorus Inc (NASDAQ: ONCR ) OncoSec Medical Inc (NASDAQ: ONCS ) Pfizer Inc. (NYSE: PFE ) ( announced U.K. regulatory nod for emergency use of its coronavirus vaccine candidate) Praxis Precision Medicines Inc (NASDAQ: PRAX ) Pulse Biosciences Inc (NASDAQ: PLSE ) Spero Therapeutics Inc (NASDAQ: SPRO ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Dec. 2) Histogen Inc (NASDAQ: HSTO ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) (shares will trade …
   The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations  2021/01/13 12:25:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alkermes Plc (NASDAQ: ALKS ) AtriCure Inc. (NASDAQ: ATRC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BIOLASE Inc (NASDAQ: BIOL ) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) CareDx Inc (NASDAQ: CDNA ) Celsius Holdings, Inc. (NASDAQ: CELH ) DermTech Inc (NASDAQ: DMTK ) Dyne Therapeutics Inc (NASDAQ: DYN ) Edap Tms SA (NASDAQ: EDAP ) Evelo Biosciences Inc (NASDAQ: EVLO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Eyenovia Inc (NASDAQ: EYEN ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Guardant Health Inc (NASDAQ: GH ) (reacted to presentation at the JPMorgan Healthcare Conference) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Laboratory Corp.
   The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue  2021/01/12 13:15:54 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) 10X Genomics Inc (NASDAQ: TXG ) AbbVie Inc (NYSE: (ABBV) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) (reacted to the company's preliminary fourth-quarter results) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Biodesix Inc (NASDAQ: BDSX ) C4 Therapeutics Inc (NASDAQ: CCCC ) CareDx Inc (NASDAQ: CDNA ) (announced preliminary fourth-quarter results) Celsius Holdings, Inc. (NASDAQ: CELH ) Chimerix Inc (NASDAQ: CMRX ) Curis, Inc. (NASDAQ: CRIS ) Dyne Therapeutics Inc (NASDAQ: DYN ) (announced positive preclinical data from its myotonic dystrophy type 1 program) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive data from midphase study of its investigational asset in treating early symptomatic Alzheimer's) ESSA Pharma Inc (NASDAQ: EPIX ) EXACT Sciences Corporation (NASDAQ: EXAS ) (reacted to preliminary fourth-quarter results) Eyenovia Inc (NASDAQ: EYEN ) Guardant Health Inc (NASDAQ: GH ) Johnson & Johnson (NYSE: JNJ ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Oxford Immunotec Global PLC (NASDAQ: OXFD ) Pacira Biosciences Inc (NASDAQ: PCRX ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Syneos Health Inc (NASDAQ: SYNH ) Theratechnologies Inc (NASDAQ: THTX ) Twist Bioscience Corp (NASDAQ: TWST ) United Therapeutics Corporation (NASDAQ: UTHR ) Vascular Biogenics Ltd (NASDAQ: VBLT ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Jan.
   The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut  2020/12/03 12:46:12 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 2) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Beam Therapeutics Inc (NASDAQ: BEAM ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Fate Therapeutics Inc (NASDAQ: FATE ) Generation Bio Co (NASDAQ: GBIO ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Inhibrx Inc (NASDAQ: INBX ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Iovance Biotherapeutics Inc (NASDAQ: IOVA ) Inspire Medical Systems Inc (NYSE: INSP ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Larimar Therapeutics Inc (NASDAQ: LRMR ) Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) (reacted to positive outlook for the cancer drug it sold to Ispen, which opens the possibility of realizing potential milestone payments) Myovant Sciences Ltd (NYSE: MYOV ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Olema Pharmaceuticals Inc (NASDAQ: OLMA ) Oncorus Inc (NASDAQ: ONCR ) OncoSec Medical Inc (NASDAQ: ONCS ) Pfizer Inc. (NYSE: PFE ) ( announced U.K. regulatory nod for emergency use of its coronavirus vaccine candidate) Praxis Precision Medicines Inc (NASDAQ: PRAX ) Pulse Biosciences Inc (NASDAQ: PLSE ) Spero Therapeutics Inc (NASDAQ: SPRO ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Dec. 2) Histogen Inc (NASDAQ: HSTO ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) (shares will trade …
   The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod  2020/12/02 12:35:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbVie Inc (NYSE: ABBV ) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT ) argenx SE – ADR (NASDAQ: ARGX ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Auris Medical Holding Ltd (NASDAQ: EARS ) (announced positive efficacy data from lab testing of AM-301 against airborne pathogens and allergens, including SARS-CoV-2) Beam Therapeutics Inc (NASDAQ: BEAM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BioNTech SE – ADR (NASDAQ: BNTX ) BioTelemetry Inc (NASDAQ: BEAT ) Blueprint Medicines Corp (NASDAQ: BPMC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) (announced FDA acceptance of NDA for infigratinib for individuals with cancer of the bile ducts) Cardiff Oncology Inc (NASDAQ: CRDF ) Cellectis SA (NASDAQ: CLLS ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Codiak BioSciences Inc (NASDAQ: CDAK ) strong>Crispr Therapeutics AG (NASDAQ: CRSP ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Foghorn Therapeutics Inc.
   Microdialysis Market: COVID-19 Business Continuity Plan | Evolving Opportunities With Amuza Inc. and Bioanalytical Systems Inc. | Technavio  2020/09/14 13:00:00 Business Wire
LONDON--(BUSINESS WIRE)-- #GlobalMicrodialysisMarket--The Global Microdialysis Market will grow by $ 0.86 mn during 2020-2024
   The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut  2020/12/03 12:46:12 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 2) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Beam Therapeutics Inc (NASDAQ: BEAM ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Fate Therapeutics Inc (NASDAQ: FATE ) Generation Bio Co (NASDAQ: GBIO ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Inhibrx Inc (NASDAQ: INBX ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Iovance Biotherapeutics Inc (NASDAQ: IOVA ) Inspire Medical Systems Inc (NYSE: INSP ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Larimar Therapeutics Inc (NASDAQ: LRMR ) Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) (reacted to positive outlook for the cancer drug it sold to Ispen, which opens the possibility of realizing potential milestone payments) Myovant Sciences Ltd (NYSE: MYOV ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Olema Pharmaceuticals Inc (NASDAQ: OLMA ) Oncorus Inc (NASDAQ: ONCR ) OncoSec Medical Inc (NASDAQ: ONCS ) Pfizer Inc. (NYSE: PFE ) ( announced U.K. regulatory nod for emergency use of its coronavirus vaccine candidate) Praxis Precision Medicines Inc (NASDAQ: PRAX ) Pulse Biosciences Inc (NASDAQ: PLSE ) Spero Therapeutics Inc (NASDAQ: SPRO ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Dec. 2) Histogen Inc (NASDAQ: HSTO ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) (shares will trade …
   The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod  2020/12/02 12:35:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbVie Inc (NYSE: ABBV ) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT ) argenx SE – ADR (NASDAQ: ARGX ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Auris Medical Holding Ltd (NASDAQ: EARS ) (announced positive efficacy data from lab testing of AM-301 against airborne pathogens and allergens, including SARS-CoV-2) Beam Therapeutics Inc (NASDAQ: BEAM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BioNTech SE – ADR (NASDAQ: BNTX ) BioTelemetry Inc (NASDAQ: BEAT ) Blueprint Medicines Corp (NASDAQ: BPMC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) (announced FDA acceptance of NDA for infigratinib for individuals with cancer of the bile ducts) Cardiff Oncology Inc (NASDAQ: CRDF ) Cellectis SA (NASDAQ: CLLS ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Codiak BioSciences Inc (NASDAQ: CDAK ) strong>Crispr Therapeutics AG (NASDAQ: CRSP ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Foghorn Therapeutics Inc.
   Microdialysis Market: COVID-19 Business Continuity Plan | Evolving Opportunities With Amuza Inc. and Bioanalytical Systems Inc. | Technavio  2020/09/14 13:00:00 Business Wire
LONDON--(BUSINESS WIRE)-- #GlobalMicrodialysisMarket--The Global Microdialysis Market will grow by $ 0.86 mn during 2020-2024
   The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment  2019/11/05 11:53:31 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 4) Agile Therapeutics Inc (NASDAQ: AGRX )(follow-on rally following positive Adcom verdict for Twirla) Amgen, Inc. (NASDAQ: AMGN ) Beigene Ltd (NASDAQ: BGNE ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Cabaletta Bio Inc (NASDAQ: CABA ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Karyopharm Therapeutics Inc (NASDAQ: KPTI )(reacted to its third-quarter results) Oyster Point Pharma Inc (NASDAQ: OYST ) (IPOed Oct. 31) Phathom Pharmaceuticals Inc (NASDAQ: PHAT ) Recro Pharma Inc (NASDAQ: REPH ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 4) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Helius Medical Technologies Inc (NASDAQ: HSDT ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Midatech Pharma PLC-ADR (NASDAQ: MTP ) Rockwell Medical Inc (NASDAQ: RMTI ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Stocks In Focus Seattle Genetics Claims Rights To Disputed Antibody-Drug Conjugate Intellectual Property Following the filing of a declaratory judgment action by DAIICHI SANKYO/S ADR (OTC: DSNKY ), Seattle Genetics, Inc. (NASDAQ: SGEN ) said the antibody-drug conjugate tech used in Daiichi Sankyo's metastatic cancer drug candidate DS-820 , among others, rightfully belongs to it. "The linker and other ADC technology used in these drug candidates are improvements to Seattle Genetics' pioneering ADC technology, the ownership of which are automatically assigned to Seattle Genetics under the terms of the agreement," the company said.
   The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study  2019/10/29 11:32:34 Benzinga Feeds
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 28.) AstraZeneca plc (NYSE: AZN ) ( reported positive clinical readout for triple combo lung cancer drug) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Cabaletta Bio Inc (NASDAQ: CABA ) (went public Oct. 25) ESSA Pharma Inc (NASDAQ: EPIX ) IGM Biosciences Inc (NASDAQ: IGMS ) Novo Nordisk A/S (NYSE: NVO ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB ) (reacted to a positive clinical readout) Down In The Dumps (Biotech stocks that hit 52-week lows Oct. 28.) Agile Therapeutics Inc (NASDAQ: AGRX ) (reported negative comments from FDA staff in the briefing document posted ahead of Twirla Adcom meeting) Bellerophon Therapeutics Inc (NASDAQ: BLPH ) CytomX Therapeutics Inc (NASDAQ: CTMX ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Gritstone Oncology Inc (NASDAQ: GRTS ) Endologix, Inc. (NASDAQ: ELGX (FDA issued a safety communication to physicians and patients regarding Endologix AFX endovascular grafts) Hoth Therapeutics Inc (NASDAQ: HOTH ) KemPharm Inc (NASDAQ: KMPH ) Miragen Therapeutics Inc (NASDAQ: MGEN ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) MOTIF BIO PLC/S ADR (NASDAQ: MTFB ) Myovant Sciences Ltd (NYSE: MYOV ) Orgenesis Inc (NASDAQ: ORGS ) Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) Stocks In Focus Mirati's KRAS Inhibitor Shows Tumor Shrinkage Mirati Therapeutics Inc (NASDAQ: MRTX ) announced the first Phase 1/2 trial results for MRTX849, an investigational KRAS G12C inhibitor, in patients with solid tumors expressing KRAS G12C mutations.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 バイオアナリティカル・システムズ BASI Bioanalytical Systems Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)